Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The impact of a 3-month continuous administration of transdermal estradiol (E2-TTS 50; 50 micrograms/day) or oral conjugated estrogen (CE; 0.625 mg/day) on glucose and lipid metabolism was investigated in two groups (n = 15/group) of postmenopausal women. Fasting levels of glucose, insulin, and C-peptide; C-peptide/insulin ratio (index of hepatic insulin clearance); and their responses to a 75-g oral glucose tolerance test (OGTT) were evaluated before and after 3 months of continuous estrogen administration. E2-TTS 50 modified carbohydrate metabolism, decreasing fasting insulin levels (P less than 0.01) and increasing the pancreatic islet response to glucose challenges, as indicated by an increased integrated value of the C-peptide curve associated with OGTT (P less than 0.05). Despite greater C-peptide secretion, integrated peripheral insulin after OGTT was decreased (P less than 0.05). The resulting increase in the integrated curve of the molar C-peptide/insulin ratio (P less than 0.01) indicated elevated hepatic insulin clearance after E2-TTS 50 administration. CE treatment did not modify carbohydrate metabolism, except for reducing fasting glucose levels (P less than 0.01). Neither therapy modified lipid metabolism, but a slight increase in circulating triglycerides (P less than 0.01) was observed during CE administration. Our data show that the addition of low doses of natural estrogens does not negatively influence glucose and lipid metabolism in postmenopausal women. By contrast, reversal of postmenopausal hypoestrogenism to early follicular phase estrogenic values with E2-TTS 50 administration seems to exert a beneficial effect on glucose metabolism by increasing hepatic insulin clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Menstrual cyclicity has a profound effect on glucose homeostasis.
Diamond, M. P., Simonson, D. C., & DeFronzo, R. A. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60842-7 · Cited by 98
Cited by
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Increased visceral fat and decreased energy expenditure during the menopausal transition
Lovejoy, J. C., Champagne, C. M., de Jonge, L., Xie, H., & Smith, S. R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.25 · Cited by 1,020
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 625
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599
“Clinical trials conducted primarily in women without diabetes have suggested that postmenopausal hormone therapy has favourable effects on at least some measures of glucose homeostasis and body composition [2, 3, 4, 5, 6, 7, 8, 9, 10].”
BackgroundResultInfluentialGodsland, I. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01699-5 · Cited by 370
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
“Cagnacci (120) NRT 15 536 2 3 mo t-E2 50 mg OGTT ↑ GSIS, ↑ HIC”
(2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Antidiabetic actions of estrogen: Insight from human and genetic mouse models
Louet, J.-F., LeMay, C., & Mauvais-Jarvis, F. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0030-9 · Cited by 284
Sex hormone binding globulin and insulin resistance
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12086 · Cited by 268
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study
Ding, E. L., Song, Y., Manson, J. E., Rifai, N., Buring, J. E., & Liu, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0785-y · Cited by 208
Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake
Campbell, S. E., & Febbraio, M. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2001 · Cited by 142
Fat Distribution and Insulin Sensitivity in Postmenopausal Women: Influence of Hormone Replacement
Munoz, J., Derstine, A., & Gower, B. A. (2002) · Obesity Research · doi:10.1038/oby.2002.59 · Cited by 94
Høeg, L., Roepstorff, C., Thiele, M., Richter, E. A., Wojtaszewski, J. F. P., & Kiens, B. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91382.2008 · Cited by 85
“Studies in postmenopausal women have shown that increased androgenicity induces a decrease in whole body insulin sensitivity and that hormonal treatment with low doses of estradiol at levels similar to those seen in the early follicular phase in premenopausal women reversed the androgen-induced decrease in whole body…”
ResultChu, M. C., Cosper, P., Nakhuda, G. S., & Lobo, R. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.043 · Cited by 82
de Figueiredo Alves, S. T., Gallichio, C. T., & Guimarães, M. M. (2006) · Gynecological Endocrinology · doi:10.1080/08916930600929586 · Cited by 24
Metadata
- Authors
- Cagnacci, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1992-06-01
- Volume
- 74
- Issue
- 6
- Pages
- 1396-1400
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1972453512
- Cited by
- 205
- References
- 1
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.